The first two authors contributed equally to this work United airway disease (UAD) concept proposed that asthma and rhinitis are both different clinical manifestation of a single inflammatory process. The aim of this study is to assess in upper and lower airways the level of inflammation and oxidative stress and to investigate the relationship between biomarkers in persistent allergic rhinitis (PER) and in concomitant asthma with PER. By a crosssectional study we measured oral and nasal (FE No ) and oral and nasal EBC 8-isoprostane, LTB 4 and PGE 2 in children with PER (n=14) and with PER and concomitant intermittent asthma (IA; n=25), mild persistent asthma (mA; n=28), moderate persistent asthma (MA; n=13) and in Healthy Controls (HCs; n=13). Oral and nasal FE NO concentrations were increased in children with PER, lA, mA and MA when compared with HCs. Nasal8-isoprostane was higher in EBC of children with PER and asthma than in HCs. Oral and nasal LTB 4 were higher in EBC of children with PER and mA than in HCs. Oral and nasal PGE 2 concentrations were higher in EBC of children with PER than in HCs. Positive correlations between oral and nasal biomarkers were found in IA for LTB4 and PGE2, in mA for FE No ' 8-isoprostane, LTB 4 and PGE 2 , and in MA for PGE 2 • No correlations were observed in children with PER and HCs. Our results suggest that non-invasive markers of inflammation and oxidative stress might be useful to study the relationships between oral and nasal compartments in allergic children with PER and concomitant asthma with the aim of defining the UAD.
presence and in the absence of symptoms. This goal may be achieved by the use of non-invasive methods and this approach might be useful also to characterize different inflammatory phenotypes of patients and to monitor their disease in order to better "personalize" the therapy. To date, only few studies have addressed the comparative use of non-invasive methods, including bronchial and nasal fractional exhaled nitric oxide (FE No ) and exhaled breath condensate (EBC), in patients with UAD (3) .
FE NO has been extensively studied as a potential non-invasive marker of asthma control and airway inflammation (1, 4) but, although the presence of correlation between FE NO levels and clinical assessment (5) and between FE NO and markers of oxidative stress, including 8-isoprostane and nitrotyrosine in EBC (6) have been demonstrated, the results supporting the routine use of these methodologies are still contradictory.
A large number of molecules measured in EBC, including leukotriene B 4 (LTB 4 ) , Prostaglandin E 2 (PGE 2 ) and 8-isoprostane, are considered a useful markers of airway inflammation and oxidative stress in the airways of asthmatic children (7) (8) (9) . LTB 4 is a pivotal biomolecule in the complex network of inflammatory mediators that characterizes allergic airway diseases; it is functionally involved in the neutrophilic inflammation of severe asthma and asthma exacerbations. Therefore, there are conflicting results on the role of LTB4 and 8-isoprostane since these markers seem to be relatively resistant to inhaled corticosteroids in allergic inflammation (9-11), although today 8-isoprostanes appear to be reliable biomarkers of oxidative stress during allergic airway inflammation (12) . The relevant contribution of PGE 2 in asthma pathogenesis has been demonstrated by its contribution to the increase of eosinophil survival (13) .
The aim of this study is to detect and to monitor the inflammation and the oxidative stress in the upper and lower airways of patients with atopic disease of UAD. This might allow to better understand the links between upper and lower airways and to have an insight in the assessment of the disease severity. In order to achieve this, we performed a cross-sectional study in atopic children with persistent AR (PER) and with different levels of asthma severity. For this objective we measured the oral and the nasal FE NO and the concentrations of 8-isoprostane, LTB 4 and PGE 2 in oral and nasal EBC of pediatric patients since the use of non-invasive techniques are simple and easy to apply in children with atopic airway disease.
MATERIALS AND METHODS

Study design
The cross-sectional study included allergic children monosensitized to house dust mites with PER with or without concomitant asthma. All of them were evaluated by performing skin prick test (SPT), spirometry, oral and nasal FEND' oral and nasal EBC collection and symptom score evaluation. Patients were studied in a stable ambient condition to avoid the influence on the reliability of the above-mentioned procedures by temperature, barometric pressure and humidity. The study was approved by the local Ethics Committee, and written informed consent was obtained from the parents of the patients enrolled in the study.
Subjects
Sixty-six children with PER and with concomitant controlled asthma (31 males and 35 females), 14 children with PER without asthma (8 males and 6 females), and 13 age-matched healthy controls (7 males and 6 females) (HCs), which had negative SPT, were consecutively enrolled. Children were recruited among outpatients attending the Pulmonology/Allergy Department of the Italian National Research Council in Palermo. The study subjects had no acute respiratory symptoms during the previous four weeks.
Assessment of PER and asthma were based on current ARIA and GINA guidelines, respectively (14) (15) . PER diagnosis was performed at the study entry according to the history of nasal symptoms and positive SPT. Among the asthmatics, 25 children had intermittent asthma (IA) (treated with short-acting~2-agonists on demand during the previous 3 months), 28 had mild persistent asthma (rnA) (treated with 100 ug of fluticasone bid during the previous two months), and 13 children had moderate persistent asthma (MA) (treated with 250 ug of fluticasone propionate plus salmeterol 50 ug bid during the previous two months). All asthmatic children had AR and concluded the treatment for rhinitis (antihistamines or topical steroid treatment) 2 months before entering the study.
No patients had acute or chronic respiratory infections or exacerbation of asthma in the previous month or anatomical nasal disorders (i.e. nasal polyposis). Within one day from the EBC collection, all subjects performed pulmonary function tests according to the international guidelines (16) .
Assessment ofatopic status
All subjects included in the study were assessed for atopic status which was established by clinical history and confirmed by SPT. Skin prick testing was performed as previously described (17) . House dust mite (Dermatophagoides pteronyssinus and Dermotophagoides farinae) monosensitized patients were included in the study to select a population as homogeneous as possible and to avoid a bias caused by other allergen exposure. Serum samples were collected, and total serum IgE and specific IgE levels were determined by CAP System (Pharmacia-Upjohn, Uppsala, Sweden).
Spirometry
Baseline (forced expiratory volume in one second) FEVI and forced vital capacity (FVC) were measured according to GINA guidelines (15) . Baseline FEVI was defined as the best of three reproducible curves. Patients were characterized by a reversible airway obstruction assessed by an increase of 15% of FEVI after inhalation of 200 ug of salbutamol.
Exhaled nitric oxide measurement
Oral and nasal FEND were determined by chemiluminescence (NIOX, Aerocrine, Sweden) following ATSIERS recommendations (18) . To evaluate the nasal F~D' the nasal samples were obtained from 1 nostril. Patients were instructed to blow up the cheeks to elevate the mouth pressure to isolate the nasal cavity from the rest ofthe respiratory system (1). The reproducibility of oral and nasal FEND with these methods was previously assessed (1).
EBC collection
Oral EBC was collected using a commercially available condenser (EcoScreen; Jaeger, Wurzburg, Germany). Children were asked to breathe at a normal frequency and tidal volume, wearing a nose clip, for 15 minutes. A median volume of 3 ml (2.6-3.5, percentiles) of oral EBC was collected.
Nasal EBC was collected according to Profita et al.
(1). After applying a nasal mask to the EcoScreen condenser, children were asked to breathe through their noses, with their mouths closed. Before collection, the subjects were asked to rinse out their mouths. An aliquot of at least 1 ml of nasal condensate was collected and stored at -80°C in disposable polypropylene sterile tubes until analysed. A median volume of 2.3 ml (1.4-2.7, percentiles) of nasal EBC was collected. The reproducibility of oral and nasal EBC biomarkers with these methods was previously assessed (1).
Alfa-amylase activity was determined to exclude salivary contamination as previously described (20) . None of EBC samples contained detectable levels of amylase activity.
EBC measurements
Concentrations of 8-isoprostane were measured with a specific RIA developed as previously described (9) . LTB 4 and PGE z (Cayman Chemical, Milan, Italy) were assessed in EBC using commercially available specific EIA kits (10, 20) . The detection limits for 8-isoprostane was 10 pg/ ml. The limits of detection were less than 6 pg/ml and 40 pg/ml for LTB 4 and PGE z respectively. The reproducibility of EBC measurements was previously assessed (1). The intra-assay and inter-assay coefficients of variation for prostanoid RIAs were as follows: 8-isoprostane, < 2% and < 3%, respectively; PGE z < 4% and < 5%, respectively. Intraclass correlation coefficient for 8-isoprostane and PGE z were 0.95 and 0.90, respectively (21) . The intraassay and inter-assay coefficients of variations for LTB 4 were < 10% and < 15%, respectively (22) . The intraclass correlation coefficient for LTB 4 was 0.72 (22) .
Data analysis
Descriptive statistics were performed and quantitative data are expressed as median and percentiles (25 to 75 %). Comparison of quantitative variables between the different groups was made by non-parametric Mann Whitney test. The correlations between variables were performed using Spearman test correlation. The P-value less than 0.05 were considered statistically significant for both non-parametric Mann Whitney test and Spearman test correlation. StatView statistical software (SAS Institute, Cary, NC, USA) was used.
RESULTS
Demographic, clinical and atopic characteristics of the subjects
Demographic, clinical and atopic characteristics of the subjects enrolled in the study are shown in Table I .
Oral and nasal FE NO
The levels of oral and nasal FE NO were significantly higher in PER and in all asthmatic children than in HCs (Fig. lA and B) . No differences were observed among allergic children (Fig. lA and  B) (Table II) .
Measurement of8-isoprostane in EBC
No significant differences were observed in 8- Results were expressed as median (25-75 percentiles) isoprostane levels in oral EBC among the study (Fig.  IC) while 8-isoprostane concentrations in nasal EBC were higher in PER (P =0.007), IA (P =0.0012), rnA (P = 0.008), and MA (P =0.006) than in HCs. No differences were observed among allergic patients ( Fig. 1D) (Table II) .
LTB4 measurements in EBe LTB 4 concentrations in oral EBC were significantly higher in children with PER (P=0.04) and rnA (P=0.012) than in HC subjects. LTB 4 concentrations in oral EBC were also higher in children with PER (P=0.04) and rnA (P=0.018) than in children with MA ( Fig. 2A) ' " -e,6OÕ
• ' "
.;; than in MA children (Fig. 2B) (Table II) .
PGE 1 measurements in E13C
The levels of PGE 2 in EBC were significantly higher in PER than in HCs (P =0.02), while lower levels were observed in MA (P=0.0026) and rnA (P = 0.014) than in PER. The concentrations ofPGE 2 in nasal ESC were higher in PER than in HC subjects (P =0.04). PGE 2 concentrations were higher in children with PER than in children with rnA (P=0.007) and MA (P=0.004). Children with IA had higher PGE 2 concentrations than children with MA .(P =0.02) (Fig. 20) (Table II) .
between bronchial and nasal FE NO concentrations (P=O.OI I, r =0.5), and between oral and nasal EBC concentrations of 8-isoprostane (P =0.0 I, r =0.5), LTB 4 (P =0.03, r = 0.5), and PGE 2 (P=O.OI, r =0.05) (Table III) .
In patients with MA, a correlation between oral and nasal EBC PGE 2 (P 0.009, r =0.8) was observed (Table III) .
No correlations between markers of bronchial and nasal oxidative stress and inflammation were observed in children with PER and in HCs (Table  III) . 4 • and PGE 1 In children with I~, positive correlations between oral and nasal EBC concentrations ofLTB 4 (P=0.007, r=0.6) and between oral and nasal EBC concentrations of PGE 2 (P =0.0004, r =0.8) were observed (Table III) .
DISCUSSION
Correlations between bronch ial and nasal FEND' 8-isoprostane, LTB
In children with rnA, there was a correlation
The present study investigates the levels of FE",o' LTB 4 , PGE 2 and 8-isoprostane in both upper and lower airway compartments of children with PER and with PER and different levels of asthma demonstrating that the presence of these markers is relevant in both districts , despite the big variability and the marginal differences in the groups. The correlations between these markers and their persistence, despite children with PER and asthma being treated for asthma, might be able to mirror a relationship between biomarkers in the two airway compartments that might be useful to monitor and to phenotype DAD.
The high levels of FE NO in both nasal and oral compartments ofMA suggest that the oxidative stress associated with FE NO might not be well controlled by recommended doses of inhaled corticosteroids (ICS). The presence of a positive correlation between the levels of oral and nasal FE NO in children with mA is a further confirmation of the DAD concept, also in these patients with low levels of asthma severity. In addition, the fact that this correlation is not present in children with PER, IA and MA is consistent with a lower inflammatory burden in PER and IA. These results could be explained by the effects of ICS promoting a modification of FE NO concentrations in both bronchial and nasal compartments of children with MA. On the other hand the issue that the assessment of relationship between bronchial and nasal levels of FE NO is able to provide information about the effect of the treatment on inflammation in asthmatic children is consistent with the observation that in children with mA, treated with lower levels of ICS than MA patients, the correlations between the oral and nasal levels of FE NO are persistent despite symptomatic and functional control of the disease.
The positive correlation between the levels of nasal and oral EBC 8-isoprostane in mA children with PER suggest that the concomitant nasobronchial evaluation of 8-isoprostane, together with the detection of the nasobronchial FE No ' may be useful to biochemically phenotype this group of asthmatic children. Finally, there was no correlation between nasal and oral EBC 8-isoprostane in MA children with PER who received higher doses of ICS, suggesting that ICS might affect the interaction of nasal and bronchial inflammation.
We observed higher levels of nasal and oral EBC LTB 4 in rnA children than in HCs, suggesting that the nasal-oral Ll'Bj-mediated inflammation persists despite treatment with ICS (9) . Finally, we found a positive correlation between nasal and oral EBC LTB 4 concentrations in children with both IA and mA, suggesting that only treatment ofboth areas, the nose and bronchi, may lead, in these specific inflammatory phenotypes, to a complete control" of upper and lower airway inflammation.
We showed higher levels of oral EBC and nasal PGE 2 concentrations in children with PER, indicating lower airway inflammation also in the absence of asthma symptoms. The presence of a positive correlation between nasal and oral EBC concentrations of PGE 2 in children with lA, rnA and MA, is in agreement with the concept of DAD and with its relevant contribution in the pathogenesis of asthma. In addition, the findings that children with stable MA had lower LTB 4 and PGE 2 concentrations in oral and nasal EBC suggest that elevated doses of ICS might control both bronchial and nasal inflammation, likely through the involvement of humoral mechanisms involved in the interaction of the upper and lower airways in DAD (23) . These results support the concept that the treatment of asthma may have a beneficial effect on the concomitant rhinitis (24) (25) .
The strength of this paper is to identify correlations between nasal and oral inflammation and oxidative stress in children with concomitant PER and different degrees of asthma defining "one-way/one-disease". The persistence of some correlations might identify inflammatory phenotypes of children with allergic airway disease and might help to plan an individualized therapy for DAD management. Nevertheless, the strong message of this paper needs to be further investigated opening new perspectives for larger and longitudinal studies aimed at assessing the concomitant evaluation of naso-bronchial markers of oxidative stress and inflammation to better manage children with DAD.
